Comerica Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.74M Buy
46,630
+10,838
+30% +$728K 0.01% 766
2025
Q3
$1.74M Buy
35,792
+3,378
+10% +$209K 0.01% 1229
2025
Q2
$2.42M Buy
32,414
+1,147
+4% +$75.9K 0.01% 1030
2025
Q1
$1.99M Sell
31,267
-36,245
-54% -$2.47M 0.01% 1113
2024
Q4
$5.27M Sell
67,512
-8,091
-11% -$650K 0.02% 659
2024
Q3
$6.08M Buy
75,603
+2,505
+3% +$202K 0.02% 595
2024
Q2
$6.05M Sell
73,098
-738
-1% -$64.9K 0.03% 588
2024
Q1
$6.3M Sell
73,836
-9,629
-12% -$756K 0.03% 602
2023
Q4
$7.14M Buy
83,465
+62,140
+291% +$5.37M 0.03% 524
2023
Q3
$1.91M Sell
21,325
-5,916
-22% -$528K 0.01% 1102
2023
Q2
$1 Buy
+27,241
New +$2.3M ﹤0.01% 655
2022
Q4
$1.92M Sell
22,405
-755
-3% -$60.7K 0.02% 1107
2022
Q3
$1.86M Sell
23,160
-10,288
-31% -$739K 0.02% 1089
2022
Q2
$2.16M Sell
33,448
-8,086
-19% -$479K 0.02% 1054
2022
Q1
$2.38M Sell
41,534
-68,969
-62% -$3.75M 0.02% 1059
2021
Q4
$5.44M Buy
110,503
+6,683
+6% +$407K 0.04% 533
2021
Q3
$7.45M Buy
103,820
+76,000
+273% +$4.8M 0.04% 463
2021
Q2
$1.6M Sell
27,820
-671
-2% -$47.5K 0.01% 1447
2021
Q1
$1.92M Sell
28,491
-1,553
-5% -$192K 0.01% 1374
2020
Q4
$3.51M Sell
30,044
-726
-2% -$78.2K 0.02% 925
2020
Q3
$3.29M Buy
30,770
+44
+0.1% +$3.85K 0.02% 808
2020
Q2
$2.83M Sell
30,726
-6,866
-18% -$694K 0.02% 852
2020
Q1
$4.39M Sell
37,592
-2,607
-6% -$283K 0.04% 498
2019
Q4
$4.39M Buy
40,199
+2,768
+7% +$335K 0.03% 605
2019
Q3
$4.5M Sell
37,431
-654
-2% -$83K 0.04% 575
2019
Q2
$4.65M Sell
38,085
-4,640
-11% -$457K 0.04% 553
2019
Q1
$3.79M Sell
42,725
-1,309
-3% -$119K 0.03% 682
2018
Q4
$4.22M Buy
44,034
+4,693
+12% +$493K 0.04% 598
2018
Q3
$4.19M Sell
39,341
-3,755
-9% -$389K 0.03% 619
2018
Q2
$4.18M Sell
43,096
-16,641
-28% -$1.41M 0.03% 754
2018
Q1
$4.52M Buy
59,737
+1,882
+3% +$129K 0.03% 683
2017
Q4
$3.79M Sell
57,855
-6,832
-11% -$360K 0.03% 858
2017
Q3
$3.05M Sell
64,687
-1,016
-2% -$42.2K 0.02% 936
2017
Q2
$2.63M Sell
65,703
-2,582
-4% -$106K 0.02% 1017
2017
Q1
$2.87M Buy
68,285
+13,151
+24% +$514K 0.02% 976
2016
Q4
$2.23M Buy
55,134
+3,233
+6% +$122K 0.02% 1118
2016
Q3
$1.89M Buy
51,901
+951
+2% +$32.6K 0.02% 1120
2016
Q2
$1.82M Sell
50,950
-1,455
-3% -$44K 0.02% 1126
2016
Q1
$1.79M Sell
52,405
-191
-0.4% -$6.17K 0.02% 1104
2015
Q4
$1.6M Buy
52,596
+321
+0.6% +$10.4K 0.02% 1131
2015
Q3
$1.69M Sell
52,275
-54,005
-51% -$2.03M 0.02% 1130
2015
Q2
$4.4M Buy
106,280
+54,128
+104% +$2.28M 0.02% 1026
2015
Q1
$2.34M Sell
52,152
-49,826
-49% -$2.08M 0.02% 985
2014
Q4
$3.82M Buy
101,978
+50,490
+98% +$1.85M 0.02% 1086
2014
Q3
$1.8M Sell
51,488
-151
-0.3% -$5.39K 0.02% 1130
2014
Q2
$1.82M Sell
51,639
-528
-1% -$17.6K 0.02% 1149
2014
Q1
$1.7M Sell
52,167
-3,886
-7% -$149K 0.01% 1241
2013
Q4
$2.36M Sell
56,053
-7,094
-11% -$292K 0.02% 1010
2013
Q3
$2.52M Buy
63,147
+1,984
+3% +$83.2K 0.02% 1005
2013
Q2
$2.53M Buy
+61,163
New +$2.48M 0.02% 831

Other funds holding HAE

Comerica Bank's HAE Position: Q4 2025 in Review

Comerica Bank increased its Haemonetics (HAE) stake by 30% in Q4 2025, buying an estimated $728K and bringing the position to 46,630 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #766.

Comerica Bank first reported a position in HAE in Q2 2013 and has held it in 50 quarters since. The position peaked at $7.45M in Q3 2021. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Comerica Bank held 46,630 shares of Haemonetics worth $3.74M as of Q4 2025.
  • Comerica Bank bought 10,838 Haemonetics shares in Q4 2025, an estimated $728K.
  • Haemonetics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #766 holding.
  • Comerica Bank first reported a position in Haemonetics in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Haemonetics position peaked at $7.45M in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.